Evidence map›Paper›PMID 31583530›Full record

ReviewAging clinical and experimental research2021

Acetylcholinesterase inhibitors targeting the cholinergic anti-inflammatory pathway: a new therapeutic perspective in aging-related disorders.

Roberta Benfante, Simona Di Lascio, Silvia Cardani, Diego Fornasari

Abstract readReview
PubMed Publisher
In one paragraph

Review in Aging clinical and experimental research, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 50 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
50citing papers in PubMed, 1 pooled it
3.0field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

50 citing papers in PubMed, 1 synthesis or guideline pooled it, 98 citations in OpenAlex.

  1. Pooled it
  2. Trial
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Roberta BenfanteCNR-Neuroscience Institute, Via Vanvitelli 32, 20129, Milan, Italy. roberta.benfante@in.cnr.it.ORCID http://orcid.org/0000-0001-5396-5429
Simona Di LascioDept. Medical Biotechnology and Translational Medicine, Università degli Studi di Milano, Via Vanvitelli 32, 20129, Milan, Italy.ORCID http://orcid.org/0000-0002-5971-1515
Silvia CardaniDept. Medical Biotechnology and Translational Medicine, Università degli Studi di Milano, Via Vanvitelli 32, 20129, Milan, Italy.ORCID http://orcid.org/0000-0001-9758-2649
Diego FornasariCNR-Neuroscience Institute, Via Vanvitelli 32, 20129, Milan, Italy.ORCID http://orcid.org/0000-0002-9668-3103
University of Milan · IT

Funding

Consiglio Nazionale delle Ricerche Research Project Aging: molecularConsiglio Nazionale delle Ricerche technological innovations for improving the health of the elderly (Prot. MIUR 2867 25.11.2011).
6 · The paper itself

Abstract

Neuroinflammation and cholinergic dysfunction, leading to cognitive impairment, are hallmarks of aging and neurodegenerative disorders, including Alzheimer's disease (AD). Acetylcholinesterase inhibitors (AChEI), the symptomatic therapy in AD, attenuate and delay the cognitive deficit by enhancing cholinergic synapses. The α7 nicotinic acetylcholine (ACh) receptor has shown a double-edged sword feature, as it binds with high affinity Aβ

Indexed as

Alzheimer DiseaseCholinesterase InhibitorsAgingalpha7 Nicotinic Acetylcholine ReceptorHumansNeuroimmunomodulationalpha7 Nicotinic Acetylcholine ReceptorCholinesterase InhibitorsChrna7 protein, humanAcetylcholinesterase inhibitorAgingCholinergic anti-inflammatory pathwayCHRFAM7ACHRNA7Neuroinflammation

Identifiers

PMID31583530
OpenAlexW2978654870

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.